MedPath

Needle-free Dental Anesthesia

Not Applicable
Suspended
Conditions
Anesthesia, Local
Needle Phobia
Interventions
Combination Product: Needle,2% lidocaine(xylocaine)
Combination Product: Meso-Jet, 2% lidocaine(xylocaine)
Registration Number
NCT04493528
Lead Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Brief Summary

Many patients experience pain and anxiety from traditional needle anesthesia and may avoid necessary dental treatments. The needle-free liquid jet injection(NFLJI) could solve these problems. NFLJI delivers drug solutions by creating a micro-thin pressure liquid jet to penetrate the skin and disperse in the soft tissue. It has many advantages like eliminating injection pain, needle phobia and needle disposal. However, anesthesia techniques in dentistry were all developed for needle injection, and they are not very effective for NFLJI. Moreover, clinical trials of dental anesthesia using NFLJI have shown inconsistent efficacy.

In this study, we aim to compare the clinical efficacy between NFLJI and needle dental anesthesia in pilot split-mouth cross-over randomized clinical trials, assess the feasibility to conduct such trial on a larger scale.

Participants will be assigned to one of the following four groups: 1. Infiltration on a maxillary lateral incisor,2. Inferior alveolar nerve block, 3.Mental nerve block, 4. Infraorbital nerve block. Each participant will receive one injection with a needle and another one with NFLJI randomly at the same appointment. A washout period of 1 hour between two procedures for participants' to forget the previous experience. Needle injection will be performed according to clinical standards. NFLJI will be performed according to a guideline developed in our research group. Participants will stay in the clinic until the anesthesia effect disappear and be followed for one week.

The primary outcome is the efficacy and effect of two anesthesia interventions. The secondary outcome is the pain and anxiety visual analogue scale before and during injection, taste preference, and complications. Additionally, patients' overall feelings for two interventions as well as any barriers to conducting such a trial will be recorded.

Detailed Description

Not available

Recruitment & Eligibility

Status
SUSPENDED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • age between 18-35 years-old
  • fluent in English
  • cooperate
Exclusion Criteria
  • has a history of chronic pain,
  • has a systematic disease,
  • has root canal therapy at the upper lateral incisor/lower posterior teeth region.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Needle Infiltration anesthesiaNeedle,2% lidocaine(xylocaine)Patients received one needle injection of infiltration anesthesia at left or right upper lateral incisors using 1 ml 2% lidocaine with 1:50,000 epinephrine (xylocaine).
Needle mental nerve blockNeedle,2% lidocaine(xylocaine)Patients received one needle injection of mental nerve block at left or right lower premolar region using 1 ml 2% lidocaine with 1:50,000 epinephrine (xylocaine).
Needle-free mandibular nerve blockMeso-Jet, 2% lidocaine(xylocaine)Patients received one NFLJI (needle-free liquid jet injection) of mandibular nerve block at left or right mandibular foramen using 2 ml 2% lidocaine with 1:50,000 epinephrine (xylocaine).
Needle-free infiltration anesthesiaMeso-Jet, 2% lidocaine(xylocaine)Patients received one NFLJI (needle-free liquid jet injection) of infiltration anesthesia at left or right upper lateral incisors using 1 ml 2% lidocaine with 1:50,000 epinephrine (xylocaine).
Needle-free mental nerve blockMeso-Jet, 2% lidocaine(xylocaine)Patients received one NFLJI (needle-free liquid jet injection) of mental nerve block at left or right lower premolar region using 1 ml 2% lidocaine with 1:50,000 epinephrine (xylocaine).
Needle mandibular nerve blockNeedle,2% lidocaine(xylocaine)Patients received one needle injection of mandibular nerve block at left or right mandibular foramen using 2 ml 2% lidocaine with 1:50,000 epinephrine (xylocaine).
Needle-free infraorbital nerve blockMeso-Jet, 2% lidocaine(xylocaine)Patients received one NFLJI (needle-free liquid jet injection) of infraorbital nerve block at left or right canine fossa using 1 ml 2% lidocaine with 1:50,000 epinephrine (xylocaine).
Needle infraorbital nerve blockNeedle,2% lidocaine(xylocaine)Patients received one needle injection of infraorbital nerve block at left or right canine fossa using 1 ml 2% lidocaine with 1:50,000 epinephrine (xylocaine).
Primary Outcome Measures
NameTimeMethod
Efficacy of dental pulp anesthesia10 minutes after injection.

The number of sucessful dental pulp anesthesia cases over total number of participants in the group.

Time to termination of anesthesia3 hours after injection

Time to termination of anesthesia feeling, measured by a simple pinch test using a periodontal probe

Dental pulp anesthesia10 minutes after injection.

Dental pulp anesthesia result is measured by an electric pulp test(EPT), successful anesthesia for dental pulp exhibits an EPT at 80.

Time to initiation of anesthesia1 minute after injection

Time to initiation of anesthesia feeling, measured by a simple pinch test using a periodontal probe

Secondary Outcome Measures
NameTimeMethod
Taste preference1 minute after the injection

Participants' taste preference after needle or needle-free injection, measured by 9-point hedonic scale for measuring food acceptability. From 1 to 9, 1 stands for "dislike extremely", 5 stands for "neither like or dislike", 9 stands for "like extremely". Higher score means a better outcome.

Incidence of adverse effect [safety]10 seconds after injection.

Incidence of adverse effect immediately after aneshesia injection, such as tissue damage, bleeding, hematoma.

Pain level during injection10 seconds after the injection

Participants' pain level when receiving the needle or needle-free injection, measured by standard visual analog scale for pain. From 0 to 10, 0 stands for "no pain", 10 stands for "worst pain". Higher score means a worse outcome.

Baseline anxiety level1 minute before injection

Participants' anxiety level before receiving the needle or needle-free injection, measured by visual analogue scale for anxiety. From 0 to 10, 0 stands for ""Not at all Anxious", 10 stands for "Extremely Anxious". Higher score means a worse outcome.

Baseline pain level1 minute before injection

Participants' pain level before receiving the needle or needle-free injection, measured by standard visual analog scale for pain. From 0 to 10, 0 stands for "no pain", 10 stands for "worst pain". Higher score means a worse outcome.

Anxiety level during injection10 seconds after the injection.

Participants' anxiety level when receiving the needle or needle-free injection, measured by visual analogue scale for anxiety.From 0 to 10, 0 stands for ""Not at all Anxious", 10 stands for "Extremely Anxious". Higher score means a worse outcome.

Incidence of adverse effect during follow-up period[safety]up to 7 days

Incidence of adverse effect after aneshesia procedure during follow-up period, such as: ulcer, hematoma, discomfort, abnormal feeling, nerve damage.

Trial Locations

Locations (1)

McGill University Faculty of Dentistry

🇨🇦

Montréal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath